[Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]

Area of Science:

• Cell Biology
• Cancer Research
• Biochemistry

Background:

• The endocannabinoid anandamide (AEA) plays complex roles in cellular processes.
• Understanding AEA's impact on liver cancer cells is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the effect of AEA on necrosis in HepG2 liver cancer cells.
• To elucidate the role of AEA in liver cancer progression.

Main Methods:

• Immunofluorescence and Western blot were used to detect fatty acid hydrolytic enzyme (FAAH) and cannabinoid receptors (CB1, CB2) in L02 and HepG2 cells.
• HepG2 cells were treated with AEA and methyl-beta-cyclodextrin (MCD), and necrosis was assessed via PI staining.
• Expression levels of p-P38 MAPK and p-JNK proteins were analyzed.

Main Results:

• FAAH, CB1, and CB2 proteins were detected in L02 and HepG2 cells, with higher FAAH in HepG2 cells.
• AEA treatment induced necrosis in HepG2 cells, an effect partially prevented by MCD.
• AEA increased p-P38 MAPK and p-JNK protein levels in a dose-dependent manner in HepG2 cells.

Conclusions:

• AEA induces necrosis in HepG2 cells through CB1 and CB2 receptors and lipid rafts.
• These findings suggest a mechanism by which AEA influences liver cancer progression.